Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.
Latest action · May 14, 2026 Referred to the House Committee on Energy and Commerce.
Progress
Where this resolution reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried. A simple resolution is the business of one chamber alone: it is not sent to the other chamber or to the President, and does not become law.
- IntroducedMay 14, 2026
- Agreed to in HouseNot reached
Cosponsors 54
Members who signed on, in the order they did. Signatures ran from May 14, 2026 to Oct 1, 2026; 12 are original cosponsors, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-MA | Ayanna Pressley | Original | May 14, 2026 |
| D-VT | Becca Balint | Original | May 14, 2026 |
| D-CO | Brittany Pettersen | Original | May 14, 2026 |
| D-DC | Eleanor Holmes Norton | Original | May 14, 2026 |
| D-VA | Jennifer L. McClellan | Original | May 14, 2026 |
| D-IL | Jesús G. "Chuy" García | Original | May 14, 2026 |
| D-MA | Katherine M. Clark | Original | May 14, 2026 |
| D-OR | Maxine Dexter | Original | May 14, 2026 |
| D-NY | Nydia M. Velázquez | Original | May 14, 2026 |
| D-NY | Paul Tonko | Original | May 14, 2026 |
| D-MA | Seth Moulton | Original | May 14, 2026 |
| D-MO | Wesley Bell | Original | May 14, 2026 |
| D-IN | André Carson | May 21, 2026 | |
| D-OR | Andrea Salinas | May 21, 2026 | |
| D-IL | Bill Foster | May 21, 2026 | |
| D-ME | Chellie Pingree | May 21, 2026 | |
| D-PA | Christopher R. Deluzio | May 21, 2026 | |
| D-CA | Dave Min | May 21, 2026 | |
| D-NC | Deborah K. Ross | May 21, 2026 | |
| D-FL | Frederica S. Wilson | May 21, 2026 | |
| D-AZ | Greg Stanton | May 21, 2026 | |
| D-NY | Gregory W. Meeks | May 21, 2026 | |
| D-WI | Gwen Moore | May 21, 2026 | |
| D-IL | Janice D. Schakowsky | May 21, 2026 | |
| D-CA | Jared Huffman | May 21, 2026 | |
| D-TX | Jasmine Crockett | May 21, 2026 | |
| D-CA | John Garamendi | May 21, 2026 | |
| D-MD | Johnny Olszewski, Jr. | May 21, 2026 | |
| D-IL | Jonathan L. Jackson | May 21, 2026 | |
| D-CA | Judy Chu | May 21, 2026 | |
| D-TX | Julie Johnson | May 21, 2026 | |
| D-FL | Kathy Castor | May 21, 2026 | |
| D-CA | Lateefah Simon | May 21, 2026 | |
| D-FL | Lois Frankel | May 21, 2026 | |
| D-MA | Lori Trahan | May 21, 2026 | |
| D-CA | Maxine Waters | May 21, 2026 | |
| D-NY | Ritchie Torres | May 21, 2026 | |
| D-CA | Salud O. Carbajal | May 21, 2026 | |
| D-KS | Sharice Davids | May 21, 2026 | |
| D-PA | Summer L. Lee | May 21, 2026 | |
| D-WA | Suzan K. DelBene | May 21, 2026 | |
| D-NY | Timothy M. Kennedy | May 21, 2026 | |
| D-OH | Emilia Strong Sykes | Jun 23, 2026 | |
| D-CA | Gilbert Ray Cisneros, Jr. | Jun 23, 2026 | |
| D-NY | Joseph D. Morelle | Jun 23, 2026 | |
| D-NJ | Josh Gottheimer | Jun 23, 2026 | |
| D-CA | Mark DeSaulnier | Jun 23, 2026 | |
| D-DE | Sarah McBride | Jun 23, 2026 | |
| D-TN | Steve Cohen | Jun 23, 2026 | |
| D-CA | Julia Brownley | Jun 24, 2026 | |
| D-MD | April McClain Delaney | Jul 15, 2026 | |
| D-NJ | Nellie Pou | Aug 20, 2026 | |
| D-TX | Lizzie Fletcher | Sep 1, 2026 | |
| D-NY | Yvette D. Clarke | Oct 1, 2026 |
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred May 14, 2026 |
Actions 2
Everything that happened, newest first.
- May 14, 2026Submitted in House
- May 14, 2026Referred to the House Committee on Energy and Commerce.
Related bills 1
Companion bills and other measures the record links to this one.
Titles 1
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 1
Each version as it was printed, newest first.
- May 14, 2026Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this resolution on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.
